Key Approvals, Notable Triumphs: April 1, 2019 Portfolio Update
FDA Clearance, Recognized Research & Progress for OIF Portfolio Companies
The back half of March was filled with impressive news about the Ohio Innovation Fund’s portfolio companies, with recognition from important industry organizations, in-depth features on their work and a major hurdle overcome. Read on to see how our portfolio companies are faring.
Genetesis Achieves FDA 510(k) Clearance for CardioFlux
Cardiac imaging technology company Genetesis Inc. recently announced the FDA 510(k) clearance of CardioFlux, its cardiac imaging platform. This clearance, which will allow Genetesis to continue moving forward with its efforts toward quick and non-invasive chest pain triage, follows an investigative study with a prototype device at Ascension St. John Hospital.
“This milestone provides emergency room physicians and cardiologists with access to new technology tomeasure and visualize the magnetic fields produced by the heart’s natural electrical activity.” –Peeyush Shrivastava, Genetesis Co-Founder and CEO
Immuta Lands Innovation Award from Technology Research Firm
451 Research, a technology research and advisory firm, has given data management company Immuta its 451 Firestarter award. The award, given quarterly by 451’s analyst-led team of experts, recognizes Immuta’s focus on rapid data access without necessitating data relocation, and on its commitment to machine learning models.
Immuta was also featured in a TechRepublic story on cybersecurity, which you can read here.
Tech Voting & Research Media Go in Eccrine Systems’ Favor
For its March Madness-inspired Tech Madness, Cincy Inno has been having its readers vote on a bracket of 32 local tech startups, and sweat sensor development company Eccrine Systems Inc. has made it all the way to the Final Four, with voting continuing through April 5. The University of Cincinnati also recently ran an in-depth feature on Eccrine Systems co-founder Jason Heikenfeld for his study, published in Nature Biotechnology, of the use of tiny portable sensors to test human biofluid.